Drugs
CGMP Violations at kdc/one Chatsworth
A 3/31-4/3 FDA inspection at the kdc/one Chatsworth drug manufacturing facility in Chatsworth, CA, found significant violations of current good manufacturing practice (CGMP) regulations for finished drugs. A just-released 9/8 Warning Letter says the violations were: * failure to have, for each batch of drug